Loading…

PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY

Saved in:

Bibliographic Details
Published in:	Value in health 2010, Vol.13 (7), p.A293-A293
Main Authors:	Schädlich, PK, Koltermann, KC, Dippel, FW, Hagenmeyer, EG, Häussler, B
Format:	Article
Language:	English
Subjects:	Internal Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!